NCT01179269View on ClinicalTrials.gov

Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

March 31, 2010

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Pazopanib plus Paclitaxel

Pazopanib daily and weekly paclitaxel IV

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Loyola University

OTHER

NCT01179269 - Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter